Business Description
Bangkok Dusit Medical Services PCL
Share Class Description:
BKK:BDMS-F: Shs Foreign RegisteredDescription
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.58 |
N/A
|
N/A
| |||
Equity-to-Asset | 0.69 |
N/A
|
N/A
| |||
Debt-to-Equity | 0.13 |
N/A
|
N/A
| |||
Debt-to-EBITDA | 0.52 |
N/A
|
N/A
| |||
Interest Coverage | 59.4 |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.57 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 5.8 |
N/A
|
N/A
| |||
3-Year EPS without NRI Growth Rate | 8.1 |
N/A
|
N/A
| |||
3-Year FCF Growth Rate | -7.5 |
N/A
|
N/A
| |||
3-Year Book Growth Rate | 5.5 |
N/A
|
N/A
| |||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 4.82 |
N/A
|
N/A
| |||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.38 |
N/A
|
N/A
|
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 85.75 |
N/A
|
N/A
| |||
9-Day RSI | 79.77 |
N/A
|
N/A
| |||
14-Day RSI | 76.85 |
N/A
|
N/A
| |||
3-1 Month Momentum % | 6.04 |
N/A
|
N/A
| |||
6-1 Month Momentum % | -4.46 |
N/A
|
N/A
| |||
12-1 Month Momentum % | -9.39 |
N/A
|
N/A
|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.16 |
N/A
|
N/A
| |||
Quick Ratio | 1.01 |
N/A
|
N/A
| |||
Cash Ratio | 0.37 |
N/A
|
N/A
| |||
Days Inventory | 15.61 |
N/A
|
N/A
| |||
Days Sales Outstanding | 37.7 |
N/A
|
N/A
| |||
Days Payable | 33.57 |
N/A
|
N/A
|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.66 |
N/A
|
N/A
| |||
Dividend Payout Ratio | 0.77 |
N/A
|
N/A
| |||
3-Year Dividend Growth Rate | 14.5 |
N/A
|
N/A
| |||
Forward Dividend Yield % | 3.9 |
N/A
|
N/A
| |||
5-Year Yield-on-Cost % | 6.89 |
N/A
|
N/A
| |||
Shareholder Yield % | 4.22 |
N/A
|
N/A
|
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.72 |
N/A
|
N/A
| |||
Operating Margin % | 17.71 |
N/A
|
N/A
| |||
Net Margin % | 13.94 |
N/A
|
N/A
| |||
EBITDA Margin % | 24.23 |
N/A
|
N/A
| |||
FCF Margin % | 10.88 |
N/A
|
N/A
| |||
OCF Margin % | 19.83 |
N/A
|
N/A
| |||
ROE % | 14.89 |
N/A
|
N/A
| |||
ROA % | 10.01 |
N/A
|
N/A
| |||
ROIC % | 11.65 |
N/A
|
N/A
| |||
3-Year ROIIC % | 12.83 |
N/A
|
N/A
| |||
ROC (Joel Greenblatt) % | 18.72 |
N/A
|
N/A
| |||
ROCE % | 15.09 |
N/A
|
N/A
| |||
Years of Profitability over Past 10-Year | 10 |
N/A
|
N/A
| |||
Moat Score | 5 |
N/A
|
N/A
| |||
Tariff Resilience Score | 8 |
N/A
|
N/A
|
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.25 |
N/A
|
N/A
| |||
Forward PE Ratio | 19.94 |
N/A
|
N/A
| |||
PE Ratio without NRI | 19.31 |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 21.72 |
N/A
|
N/A
| |||
PEG Ratio | 1.82 |
N/A
|
N/A
| |||
PS Ratio | 2.69 |
N/A
|
N/A
| |||
PB Ratio | 2.73 |
N/A
|
N/A
| |||
Price-to-Tangible-Book | 3.34 |
N/A
|
N/A
| |||
Price-to-Free-Cash-Flow | 24.74 |
N/A
|
N/A
| |||
Price-to-Operating-Cash-Flow | 13.57 |
N/A
|
N/A
| |||
EV-to-EBIT | 15.75 |
N/A
|
N/A
| |||
EV-to-Forward-EBIT | 14.9 |
N/A
|
N/A
| |||
EV-to-EBITDA | 11.66 |
N/A
|
N/A
| |||
EV-to-Forward-EBITDA | 10.99 |
N/A
|
N/A
| |||
EV-to-Revenue | 2.82 |
N/A
|
N/A
| |||
EV-to-Forward-Revenue | 2.69 |
N/A
|
N/A
| |||
EV-to-FCF | 25.56 |
N/A
|
N/A
| |||
Price-to-GF-Value | 0.73 |
N/A
|
N/A
| |||
Price-to-Projected-FCF | 1.21 |
N/A
|
N/A
| |||
Price-to-DCF (Earnings Based) | 1.53 |
N/A
|
N/A
| |||
Price-to-DCF (FCF Based) | 1.32 |
N/A
|
N/A
| |||
Price-to-Median-PS-Value | 0.57 |
N/A
|
N/A
| |||
Price-to-Peter-Lynch-Fair-Value | 1.77 |
N/A
|
N/A
| |||
Price-to-Graham-Number | 1.69 |
N/A
|
N/A
| |||
Earnings Yield (Greenblatt) % | 6.36 |
N/A
|
N/A
| |||
FCF Yield % | 3.98 |
N/A
|
N/A
| |||
Forward Rate of Return (Yacktman) % | 15.05 |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bangkok Dusit Medical Services PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 111,601.95 | ||
| EPS (TTM) (฿) | 0.98 | ||
| Beta | 0.47 | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -0.96 | ||
| Volatility % | 16.42 | ||
| 14-Day RSI | 76.85 | ||
| 14-Day ATR (฿) | 0.1 | ||
| 20-Day SMA (฿) | 20.04 | ||
| 12-1 Month Momentum % | -9.39 | ||
| 52-Week Range (฿) | 17.5 - 25.5 | ||
| Shares Outstanding (Mil) | 15,892 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bangkok Dusit Medical Services PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bangkok Dusit Medical Services PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.250000 Cash Dividend | 2026-03-10 | 19.20 (+0.00%) | ||
| THB 0.400000 Cash Dividend | 2026-03-10 | 19.20 (+0.00%) | ||
| THB 0.350000 Cash Dividend | 2025-09-09 | 20.90 (+0.00%) | ||
| THB 0.400000 Cash Dividend | 2025-03-12 | 23.20 (+0.00%) | ||
| THB 0.350000 Cash Dividend | 2024-09-10 | 29.00 (+0.00%) | ||
| 10:1 Stock Split | 2014-04-29 | 15.50 (+0.00%) |
Show
Entries
Bangkok Dusit Medical Services PCL Frequently Asked Questions
What is Bangkok Dusit Medical Services PCL(BKK:BDMS-F)'s stock price today?
The current price of BKK:BDMS-F is ฿20.50. The 52 week high of BKK:BDMS-F is ฿25.50 and 52 week low is ฿17.50.
When is next earnings date of Bangkok Dusit Medical Services PCL(BKK:BDMS-F)?
The next earnings date of Bangkok Dusit Medical Services PCL(BKK:BDMS-F) is .
Does Bangkok Dusit Medical Services PCL(BKK:BDMS-F) pay dividends? If so, how much?
The Dividend Yield %  of Bangkok Dusit Medical Services PCL(BKK:BDMS-F) is 3.66% (As of Today), Highest Dividend Payout Ratio of Bangkok Dusit Medical Services PCL(BKK:BDMS-F) was 1.6. The lowest was 0.61. And the median was 0.71. The  Forward Dividend Yield % of Bangkok Dusit Medical Services PCL(BKK:BDMS-F) is 3.9%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bangkok Dusit Medical Services PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers